"Comparative Safety of GLP-1/GIP Co-Agonists vs GLP-1 Receptor Agonists." Diabetes Obes Metab
Free of fragrance, it is ideal for all skin types, including dry and sensitive skin, ensuring a non-irritating experience
A number of studies have demonstrated sustained weight loss post-medication removal
Findings from clinical trials also suggest that movement helps counteract changes in muscle and supports better blood sugar control, especially for patients with insulin resistance
GLP-1 (17 mg/mL): A dual GLP-1 and GIP receptor agonist that activates natural hormonal pathways to regulate appetite, improve glycemic control, enhance insulin sensitivity, and support fat loss
Obesity also drives insulin resistance, which lowers the carrier protein (SHBG) that keeps testosterone in circulation